Baylor
New Data in Kidney Cancer Bolsters Promise of Mass Spec Technique for Assessing Surgical Margins
Premium
Investigators hope they can establish the technology in kidney cancer and other tumor types to improve surgery success and associated survival outcomes.
Pediatric Patients Face Barriers Receiving Exome Sequencing From Insurance, Scheduling Delays
Premium
A recent analysis found that it can take between five days and more than a year from when testing is first considered to sample collection.
The program sequenced 77 genes from more than 10,000 patients and determined how to implement the data into the medical center's electronic medical record.
Is Abbott Antigen Test Answer to US COVID-19 Testing Problems? Stakeholders Emphasize Caution
Some lab experts say that Abbott's test is open to multiple variables, which could lead to improper use and incorrect test results.
Emerging COVID-19 Viral Genome Sequencing Assays Provide Alternative to Existing Diagnostics
Several groups are developing diagnostic viral genome sequencing assays and panels, which promise high sensitivity and additional information on viral origin and spread.
Apr 25, 2019
Nov 9, 2017